KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TGM4 | Transglutaminase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
RLN1 | Relaxin 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
DEFB132 | Defensin, beta 132 | Predicted secreted proteins
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
CHRNA2 | Cholinergic receptor, nicotinic, alpha 2 (neuronal) | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
POTEH | POTE ankyrin domain family, member H | Predicted intracellular proteins
| | | | | Group enriched |
FOXI1 | Forkhead box I1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PRAC1 | Prostate cancer susceptibility candidate 1 | Predicted intracellular proteins
| | | | | Group enriched |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
POTEM | POTE ankyrin domain family, member M | Predicted intracellular proteins
| | | | | Group enriched |
LRRC26 | Leucine rich repeat containing 26 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LRTM1 | Leucine-rich repeats and transmembrane domains 1 | Predicted membrane proteins
| | | | | Group enriched |
SALL3 | Spalt-like transcription factor 3 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
MSMB | Microseminoprotein, beta- | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
PLA2G4D | Phospholipase A2, group IVD (cytosolic) | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
OR51E2 | Olfactory receptor, family 51, subfamily E, member 2 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SP8 | Sp8 transcription factor | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
SRD5A2 | Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CACNG4 | Calcium channel, voltage-dependent, gamma subunit 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CD177 | CD177 molecule | Predicted secreted proteins
| | | | | Group enriched |
CPNE4 | Copine IV | Predicted intracellular proteins
| | | | | Group enriched |
STEAP2 | STEAP family member 2, metalloreductase | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TMEFF2 | Transmembrane protein with EGF-like and two follistatin-like domains 2 | Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | Predicted intracellular proteins
| | | | | Group enriched |
PRAC2 | Prostate cancer susceptibility candidate 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
RP11-350O14.18 | | Predicted secreted proteins
| | | | | Group enriched |
EVX2 | Even-skipped homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NEFH | Neurofilament, heavy polypeptide | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
RFPL2 | Ret finger protein-like 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
SOX14 | SRY (sex determining region Y)-box 14 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
NCAPD3 | Non-SMC condensin II complex, subunit D3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
NKX3-1 | NK3 homeobox 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
SERPINB11 | Serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene) | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
TBL1Y | Transducin (beta)-like 1, Y-linked | Predicted intracellular proteins
| | | | | Tissue enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACOXL | Acyl-CoA oxidase-like | Predicted intracellular proteins
| | | | | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NELL1 | NEL-like 1 (chicken) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
RDH11 | Retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
TRPM8 | Transient receptor potential cation channel, subfamily M, member 8 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |